[Myo-inositol in the treatment of polycystic ovary syndrome].

Abstract

OBJECTIVE:

Presentation of a comprehensive body of knowledge on the role of insulin sensitizer myo-inositol in the treatment of polycystic ovary syndrome (PCOS).

DESIGN:

Review article.

SETTING:

Institute for the Care of Mother and Child, Prague.

METHOD:

An overview of publishing data.

RESULTS AND CONCLUSION:

Polycystic ovary syndrome is the most common cause of ovarian dysfunction and anovulatory infertility in women. The insulin resistance occurs very frequently as a part of PCOS. This paper reviews the literature documenting the effectiveness of insulin sensitizer myo-inositol in the treatment of ovarian dysfunction, symptoms of hyperandrogenism and wide complex of symptoms of metabolic syndrome. Six randomized controlled trials provides evidence of a positive effect of myo-inositol to normalize ovarian function, improve laboratory and clinical manifestations of hyperandrogenism and insulin resistance. The myo-inositol treatment has been demonstrated as a safe method of PCOS management.

• Authors: P Křepelka
• Journal: Ceska gynekologie (Ceska Gynekol) Vol. 79 Issue 3 Pg. 242-6 (Jun 2014) ISSN: 1210-7832 [Print] Czech Republic
• Vernacular Title: Myoinositol v terapii syndromu polycystických ovarií
• PMID: 25054962 (Publication Type: Journal Article, Review)

Chemical References

• Vitamin B Complex
• Inositol

Topics

• Female
• Humans
• Inositol (therapeutic use)
• Polycystic Ovary Syndrome (drug therapy)
• Vitamin B Complex (therapeutic use)